DK0974055T3 - Fremgangsmåde til titrering af en kompleks virussammensætning - Google Patents

Fremgangsmåde til titrering af en kompleks virussammensætning

Info

Publication number
DK0974055T3
DK0974055T3 DK98917302T DK98917302T DK0974055T3 DK 0974055 T3 DK0974055 T3 DK 0974055T3 DK 98917302 T DK98917302 T DK 98917302T DK 98917302 T DK98917302 T DK 98917302T DK 0974055 T3 DK0974055 T3 DK 0974055T3
Authority
DK
Denmark
Prior art keywords
viruses
species
titrating
type
virus composition
Prior art date
Application number
DK98917302T
Other languages
English (en)
Inventor
Catherine Gerdil
Jean-Francois Saluzzo
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of DK0974055T3 publication Critical patent/DK0974055T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK98917302T 1997-04-04 1998-04-03 Fremgangsmåde til titrering af en kompleks virussammensætning DK0974055T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704371A FR2761698B1 (fr) 1997-04-04 1997-04-04 Methode de titrage d'une composition virale complexe
PCT/FR1998/000678 WO1998045709A1 (fr) 1997-04-04 1998-04-03 Methode de titrage d'une composition virale complexe

Publications (1)

Publication Number Publication Date
DK0974055T3 true DK0974055T3 (da) 2003-07-21

Family

ID=9505710

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98917302T DK0974055T3 (da) 1997-04-04 1998-04-03 Fremgangsmåde til titrering af en kompleks virussammensætning

Country Status (15)

Country Link
US (1) US6890711B1 (da)
EP (1) EP0974055B1 (da)
KR (1) KR100543344B1 (da)
CN (1) CN1130465C (da)
AT (1) ATE235685T1 (da)
AU (1) AU737465B2 (da)
BR (1) BR9808482A (da)
CA (1) CA2285647C (da)
DE (1) DE69812601T2 (da)
DK (1) DK0974055T3 (da)
ES (1) ES2191299T3 (da)
FR (1) FR2761698B1 (da)
NZ (1) NZ500005A (da)
PT (1) PT974055E (da)
WO (1) WO1998045709A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159969A1 (fr) * 2000-05-30 2001-12-05 Aventis Pasteur Vaccine composition
US8589667B2 (en) 2010-04-19 2013-11-19 Apple Inc. Booting and configuring a subsystem securely from non-local storage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511702B1 (fr) * 1981-08-24 1985-09-13 Pasteur Institut Anticorps monoclonaux antipoliovirus pour l'identification du type et la differenciation intratypique de souches isolees de poliovirus, hybrides cellulaires pour leur fabrication et procede de diagnostic in vitro mettant en jeu des anticorps
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
FR2694022B1 (fr) * 1992-07-21 1994-09-30 Int Mycoplasma Procédé d'amplification des agents infectieux en diagnostic "in vitro" sur cultures cellulaires.
JPH06222062A (ja) * 1993-01-22 1994-08-12 Teijin Ltd ウイルス感染価および中和抗体価の測定法

Also Published As

Publication number Publication date
PT974055E (pt) 2003-08-29
NZ500005A (en) 2001-07-27
ATE235685T1 (de) 2003-04-15
DE69812601D1 (de) 2003-04-30
AU737465B2 (en) 2001-08-23
DE69812601T2 (de) 2003-10-09
FR2761698B1 (fr) 1999-05-07
EP0974055A1 (fr) 2000-01-26
AU7055298A (en) 1998-10-30
FR2761698A1 (fr) 1998-10-09
CA2285647A1 (fr) 1998-10-15
CA2285647C (fr) 2008-11-18
EP0974055B1 (fr) 2003-03-26
KR20010006045A (ko) 2001-01-15
US6890711B1 (en) 2005-05-10
BR9808482A (pt) 2001-07-31
CN1259207A (zh) 2000-07-05
ES2191299T3 (es) 2003-09-01
KR100543344B1 (ko) 2006-01-20
CN1130465C (zh) 2003-12-10
WO1998045709A1 (fr) 1998-10-15

Similar Documents

Publication Publication Date Title
DK0933082T3 (da) Fremgangsmåde til manipulation af celledifferentiering
DE69230146D1 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
EP1379693A4 (en) BIO STICK CODES BASED ON OLIGONUCLEOTIDE-MODIFIED PARTICLES
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
DK61890D0 (da) Fremgangsmaade til bestemmelse af antigener ved hjaelp af to eller flere monoklonale antistoffer
DK0920631T3 (da) Fremgangsmåde til identifikation af forbindelser, som indvirker på interaktioner mellem RNA og RNA-bindende proteiner
AUPO351996A0 (en) Viral variants and methods for detecting same
DK99682A (da) Immunoanalysemetoder under anvendelse af monoklonale antistoffer
DK226782A (da) Svingningstypediskriminerende apparat, f.eks. til lasergyroskoper
DK0539435T3 (da) Fremgangsmåde til nedsættelse af interferenser ved en bestemmelse ved fluorescens
ATE309540T1 (de) Analytisches verfahren unter verwendung von multipelviren-markierung
DK0902286T3 (da) Immunanalyse med anvendelse af to inkubationer med mærket antigen
ATE221657T1 (de) Entstörung durch rheumafaktoren
DK0709455T3 (da) Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
DK0974055T3 (da) Fremgangsmåde til titrering af en kompleks virussammensætning
DK1141026T3 (da) Sammensætninger og fremgangsmåder til frembringelse af monoklonale antistoffer repræsentative for en specifik celletype
DK0740789T3 (da) Fremgangsmåde til at teste for mastitis i pattedyr samt system til udøvelse af fremgangsmåden
CA2419046A1 (en) Method for detecting or measuring hbv
DE69738503D1 (de) Den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte
IS5620A (is) Greiningar aðferðir
DK437087A (da) Monoklont antistof til bestemmelse af humant glycoalbumin
DE3679926D1 (de) Nachweis von human-t-zellen-leukemievirus des typs-iii.
DK0556320T3 (da) Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
ATE307201T1 (de) Srcr domäne-enthaltendes protein